Follow Us
© 2026 Arizent. All rights reserved.
John Crable is Senior Vice President of Corporate Synergies. He specializes in reducing cost through plan design study, claim analysis, creative funding and diligent negotiations.
For reprint and licensing requests for this article, click here.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Setting clear expectations and equipping health plan members with usable information will build trust and eliminate employee friction in the face of change.
A look at traditional PBMs and pass-through models, potential savings areas, developments and partnering with the right consultant.
Part one of this two-part series looks at the background, transparency solutions and how to understand PBM profitability.
The practical value of a guarantee depends heavily on the contract terms that sit behind the headline.
